Improving Memory

  • Author: Melania Tesio
  • Published: 22 June 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: eLife
thumbnail image: Improving Memory

Long-term memory, namely the capacity of storing information for a long period of time, depends on protein synthesis. This event is triggered by eIF2α (eukaryotic translation initiation factor 2α). When present in its unphosphorylated state, this protein initiates the translation of RNA into proteins. Conversely, eIF2α becomes inactive when phosphorylated. In this condition, protein synthesis is blocked and the long-term memory impaired.

Carmela Sidrauski, University of California, USA, and colleagues discovered ISRIB (pictured), a molecule which renders the cells insensitive to eIF2α phosphorylation. The new compound, a symmetric bis-glycolamide with a central bi-substituted cyclohexane, increased protein synthesis and improved long term memory when administered to rodents. Moreover, it showed good pharmacokinetic properties and it did not elicit toxic effects.

ISRIB might, therefore, constitute a useful treatment for diseases associated to memory impairment.

Article Views: 2694

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH